Propiverine

Chemical formula: C₂₃H₂₉NO₃  Molecular mass: 367.481 g/mol  PubChem compound: 4942

Therapeutic indications

Propiverine is indicated for:

Overactive bladder syndrome, neurogenic detrusor overactivity

Population group: only adults (18 years old or older)

Symptomatic treatment of urinary incontinence and/or increased urinary frequency and urgency in patients with overactive bladder syndrome or neurogenic detrusor overactivity from spinal cord injuries.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Propiverine is contraindicated in the following cases:

Bowel obstruction, intestinal atony, severe ulcerative colitis, toxic megacolon

at least one of
Intestinal obstruction
Atony of colon
Colitis gravis
† Toxic megacolon

Tachyarrhythmia

Tachyarrhythmia

Moderate or severe hepatic impairment

at least one of
Hepatic failure stage III
Hepatic failure stage IV

Uncontrolled angle closure glaucoma

Angle-closure glaucoma

Μyasthenia gravis

Myasthenia gravis

Bladder outflow obstruction, urinary retention

at least one of
Bladder outflow obstruction
Retention of urine

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: DETRUNORM Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈